412 related articles for article (PubMed ID: 33564173)
1. Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
[TBL] [Abstract][Full Text] [Related]
2. Care for patients with multiple endocrine neoplasia type 1: the current evidence base.
Pieterman CR; Vriens MR; Dreijerink KM; van der Luijt RB; Valk GD
Fam Cancer; 2011 Mar; 10(1):157-71. PubMed ID: 21061174
[TBL] [Abstract][Full Text] [Related]
3. Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1.
Yates CJ; Newey PJ; Thakker RV
Lancet Diabetes Endocrinol; 2015 Nov; 3(11):895-905. PubMed ID: 26165399
[TBL] [Abstract][Full Text] [Related]
4. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.
Donati S; Ciuffi S; Marini F; Palmini G; Miglietta F; Aurilia C; Brandi ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066578
[TBL] [Abstract][Full Text] [Related]
5. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
Pieterman CRC; Hyde SM; Wu SY; Landry JP; Chiang YJ; Christakis I; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
Surgery; 2021 Jan; 169(1):175-184. PubMed ID: 32703679
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
8. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
Giusti F; Cianferotti L; Boaretto F; Cetani F; Cioppi F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Fossi C; Giudici F; Gronchi G; Loli P; Mantero F; Marcocci C; Marini F; Masi L; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Sciortino G; Spada A; Tomassetti P; Tonelli F; Brandi ML
Endocrine; 2017 Nov; 58(2):349-359. PubMed ID: 28132167
[TBL] [Abstract][Full Text] [Related]
10. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
12. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
14. Update on multiple endocrine neoplasia Type 1 and 2.
Al-Salameh A; Baudry C; Cohen R
Presse Med; 2018 Sep; 47(9):722-731. PubMed ID: 29909163
[TBL] [Abstract][Full Text] [Related]
15. Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1.
van den Broek MFM; van Nesselrooij BPM; Pieterman CRC; Verrijn Stuart AA; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Havekes B; Kerstens MN; Bisschop PH; Valk GD
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32396602
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
[TBL] [Abstract][Full Text] [Related]
17. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.
Vannucci L; Marini F; Giusti F; Ciuffi S; Tonelli F; Brandi ML
Endocrine; 2018 Feb; 59(2):438-448. PubMed ID: 28530019
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
19. 10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods.
Clerici T; Schmid C; Komminoth P; Lange J; Spinas GA; Brändle M
Swiss Med Wkly; 2001 Jun; 131(25-26):381-6. PubMed ID: 11524904
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
